Scholar IQ
Try ScholarIQ free
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

National Institute on Aging

InstitutionResearch output, impact & collaborations

National Institute on Aging is a institution indexed in ScholarIQ from OpenAlex.

What is known about National Institute on Aging?

ScholarIQrecord summary

National Institute on Aging is a research organisation in Baltimore, US. OpenAlex records 21,721 works and 6,341,869 citations for it. 2,858 researchers list it as their most recent affiliation.

How many works does National Institute on Aging have?

ScholarIQindexed works

National Institute on Aging has 21,721 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does National Institute on Aging have?

ScholarIQcitation count

National Institute on Aging has 6,341,869 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at National Institute on Aging?

ScholarIQresearcher count

National Institute on Aging has 2,858 researchers in the ScholarIQ index.

What is the average h-index at National Institute on Aging?

ScholarIQavg h-index

National Institute on Aging has an average h-index of 75.5 in OpenAlex.

What is the ROR of National Institute on Aging?

ScholarIQror

The ROR for National Institute on Aging is on the source record.

What is the OpenAlex record for National Institute on Aging?

ScholarIQopenalex

The OpenAlex for National Institute on Aging is on the source record.

Who are the most-cited researchers behind National Institute on Aging?

ScholarIQtop researchers by citations
1
David Schlessinger · RNA and protein synthesis mechanisms
526 works62,344 citations
2
Rafael de Cabo · Adipose Tissue and Metabolism
488 works56,088 citations
3
David J. Stott · Frailty in Older Adults
354 works26,797 citations
4
Patrice J. Morin · Ovarian cancer diagnosis and treatment
161 works24,683 citations
5
Melissa E. Garcia · Genetic Associations and Epidemiology
91 works23,287 citations

What are the most-cited papers on National Institute on Aging?

ScholarIQmost cited works
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Richard S.E. Keefe, Sonia M. Davis, C.E. Davis, Barry D. Lebowitz, Joanne B. Severe, John Hsiao
New England Journal of Medicine. 20055,913 CitationsOPEN ACCESS
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
James Shepherd, Gerard J. Blauw, Michael Murphy, Edward Bollen, Brendan M. Buckley, Stuart M. Cobbe, Ian Ford, Allan Gaw, Michael E. Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, A. Edo Meinders, John Norrie, Chris J. Packard, Ivan J. Perry, David J. Stott, Brian Sweeney, Gillian Twomey, Rudi GJ Westendorp
The Lancet. 20023,397 Citations
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar, David Preiss, Heather Murray, Paul Welsh, Brendan M. Buckley, Anton JM de Craen, Sreenivasa Rao Kondapally Seshasai, John J.V. McMurray, Dilys J. Freeman, J. Wouter Jukema, Peter W. Macfarlane, Chris J. Packard, David J. Stott, Rudi G. J. Westendorp, James Shepherd, Barry R. Davis, Sara Pressel, Roberto Marchioli, Rosa Maria Marfisi, Aldo P. Maggioni, Luigi Tavazzi, Gianni Tognoni, John Kjekshus, Terje R. Pedersen, Thomas J. Cook, Antonio M. Gotto, Michael Clearfield, John R. Downs, Haruo Nakamura, Yasuo Ohashi, Kyoichi Mizuno, Kausik K. Ray, Ian Ford
The Lancet. 20102,456 Citations
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Lon S. Schneider, Pierre N. Tariot, Karen Dagerman, Sonia M. Davis, John Hsiao, M. Saleem Ismail, Barry D. Lebowitz, Constantine G. Lyketsos, J. Michael Ryan, T. Scott Stroup, David L. Sultzer, Daniel Weintraub, Jeffrey A. Lieberman
New England Journal of Medicine. 20061,199 CitationsOPEN ACCESS
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
Joseph P. McEvoy, Jeffrey A. Lieberman, T. Scott Stroup, Sonia M. Davis, Herbert Y. Meltzer, Robert A. Rosenheck, Marvin S. Swartz, Diana O. Perkins, Richard S.E. Keefe, C.E. Davis, Joanne B. Severe, John Hsiao, for the CATIE Investigators
American Journal of Psychiatry. 2006757 Citations

How much of the research on National Institute on Aging is open access?

ScholarIQopen access share
56%OPEN ACCESS
Gold
0%
Green
11%
Hybrid
0%
Bronze
44%
Closed
44%

Related on ScholarIQ

Dementia and Cognitive Impairment Research
Top Topic
Alzheimer's disease research and treatments
Top Topic
Parkinson's Disease Mechanisms and Treatments
Top Topic
DNA Repair Mechanisms
Top Topic
Nutrition and Health in Aging
Top Topic
Genetics, Aging, and Longevity in Model Organisms
Top Topic
470M+ articles · 14-day free trial